BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND EBF1, COE1, 1879, ENSG00000164330, Q9UH73, OLF1, O/E-1, EBF
125 results:

  • 1. Transcriptome Analysis in Mexican Adults with Acute Lymphoblastic Leukemia.
    Cruz-Miranda GM; Olarte-Carrillo I; Bárcenas-López DA; Martínez-Tovar A; Ramírez-Bello J; Ramos-Peñafiel CO; García-Laguna AI; Cerón-Maldonado R; May-Hau D; Jiménez-Morales S
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339034
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
    Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
    Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ebf1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas.
    Turdo A; Gaggianesi M; D'Accardo C; Porcelli G; Bella SD; Cricchio D; Pillitteri I; Porcasi R; Lo Iacono M; Verona F; Modica C; Roozafzay N; Florena AM; Stassi G; Mancuso S; Todaro M
    Front Immunol; 2023; 14():1266265. PubMed ID: 38035116
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients.
    Yuan X; Yu T; Zhao J; Jiang H; Hao Y; Lei W; Liang Y; Li B; Qian W
    Front Med; 2023 Oct; 17(5):889-906. PubMed ID: 37418076
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes].
    Hu WD; Li B; Su SF; Liu YF; Liu W; Zhang WL; Zuo WL; Yu RH
    Zhonghua Er Ke Za Zhi; 2023 May; 61(5):446-452. PubMed ID: 37096265
    [No Abstract]    [Full Text] [Related]  

  • 6. Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.
    Parsons MW; Rock C; Chipman JJ; Shah HR; Hu B; Stephens DM; Tao R; Tward JD; Gaffney DK
    Cancer Med; 2023 Feb; 12(3):2624-2636. PubMed ID: 36812123
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. INPP5K controls the dynamic structure and signaling of wild-type and mutated, leukemia-associated IL-7 receptors.
    Moës B; Li H; Molina-Ortiz P; Radermecker C; Rosu A; Vande Catsyne CA; Sayyed SA; Fontela J; Duque M; Mostafa A; Azzi A; Barata JT; Merino R; Xu C; Desmet CJ; Schurmans S
    Blood; 2023 Apr; 141(14):1708-1717. PubMed ID: 36599086
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
    Coupier A; Gallien Y; Boillot O; Walter T; Guillaud O; Vallin M; Thimonier E; Erard D; Dumortier J
    Clin Transplant; 2023 Jan; 37(1):e14841. PubMed ID: 36394373
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.
    Jang JY; Hwang I; Pan H; Yao J; Alinari L; Imada E; Zanettini C; Kluk MJ; Wang Y; Lee Y; Lin HV; Huang X; Di Liberto M; Chen Z; Ballman KV; Cantley LC; Marchionni L; Inghirami G; Elemento O; Baiocchi RA; Chen-Kiang S; Belvedere S; Zheng H; Paik J
    J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36282572
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeted Treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic Leukemia.
    Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
    Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A Novel Prognostic Score Including the CD4/CD8 for AIDS-Related lymphoma.
    Chen J; Liu X; Qin S; Ruan G; Lu A; Zhang J; Wu Y; Xie Z; Peng J
    Front Cell Infect Microbiol; 2022; 12():919446. PubMed ID: 35873145
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
    Venn NC; Huang L; Hovorková L; Muskovic W; Wong M; Law T; Heatley SL; Khaw SL; Revesz T; Dalla Pozza L; Shaw PJ; Fraser C; Moore AS; Cross S; Bendak K; Norris MD; Henderson MJ; White DL; Cowley MJ; Trahair TN; Zuna J; Sutton R
    Br J Cancer; 2022 Sep; 127(5):908-915. PubMed ID: 35650277
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. How to resist Notch-targeted T-leukemia therapy: Lineage- and MYC enhancer switch.
    Bayer M; Grosschedl R
    Mol Cell; 2022 Mar; 82(5):884-886. PubMed ID: 35245453
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. ebf1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells.
    Zhou Y; Petrovic J; Zhao J; Zhang W; Bigdeli A; Zhang Z; Berger SL; Pear WS; Faryabi RB
    Mol Cell; 2022 Mar; 82(5):1003-1020.e15. PubMed ID: 35182476
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformation.
    Lee RD; Munro SA; Knutson TP; LaRue RS; Heltemes-Harris LM; Farrar MA
    Nat Commun; 2021 Nov; 12(1):6843. PubMed ID: 34824268
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
    Moorman AV; Barretta E; Butler ER; Ward EJ; Twentyman K; Kirkwood AA; Enshaei A; Schwab C; Creasey T; Leongamornlert D; Papaemmanuil E; Patrick P; Clifton-Hadley L; Patel B; Menne T; McMillan AK; Harrison CJ; Rowntree CJ; Marks DI; Fielding AK
    Leukemia; 2022 Mar; 36(3):625-636. PubMed ID: 34657128
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.
    Heltemes-Harris LM; Hubbard GK; LaRue RS; Munro SA; Yang R; Henzler CM; Starr TK; Sarver AL; Kornblau SM; Farrar MA
    Oncogene; 2021 Oct; 40(43):6166-6179. PubMed ID: 34535769
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers.
    Andrews JM; Pyfrom SC; Schmidt JA; Koues OI; Kowalewski RA; Grams NR; Sun JJ; Berman LR; Duncavage EJ; Lee YS; Cashen AF; Oltz EM; Payton JE
    EBioMedicine; 2021 Sep; 71():103559. PubMed ID: 34461601
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Proposal and clinical application of molecular genetic risk scoring system, "MRplus", for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre.
    Gupta SK; Bakhshi S; Kamal VK; Gupta R; Sharma P; Pushpam D; Sahoo RK; Sharma A
    Leuk Res; 2021 Dec; 111():106683. PubMed ID: 34371436
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan.
    Hsu YC; Yu CH; Chen YM; Roberts KG; Ni YL; Lin KH; Jou ST; Lu MY; Chen SH; Wu KH; Chang HH; Lin DT; Lin SW; Lin ZS; Chiu WT; Chang CC; Ho BC; Mullighan CG; Yu SL; Yang YL
    Sci Rep; 2021 Mar; 11(1):5802. PubMed ID: 33707599
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.